2m 2m 2m 2m 2m 2m 2m
ACTINIUM PHARMA (ATNM)
NYSE
$0.90-$0.01 (-1.10%)
Price as of Jul 14, 2026 12:34 PM EDT- $28.4MMarket Cap
- -42.36%1-Year Change
- BiotechnologyIndustry
ACTINIUM PHARMA (ATNM)
$0.90-$0.01 (-1.10%)
ATNM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.91 | ||
Change | -$0.02 (-2.69%) | ||
Open | $0.92 | ||
High | $0.97 | ||
Low | $0.90 | ||
Previous Close | $0.93 | ||
Volume | 96,428 | ||
30-Day Average Volume | 120,606 | ||
1-Week Change | -5.83% | ||
1-Month Change | -10.40% | ||
1-Year Change | -42.36% | ||
3-Year Change | -87.34% | ||
5-Year Change | -87.03% | ||
Fundamentals | |||
Shares Outstanding | 31.4M | ||
Total Assets | $45.4M | ||
Market Cap | $28.4M | ||
Enterprise Value | -$13.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$5.5M | ||
Free Cash Flow | -$5.9M | ||
EBIT | -$5.5M | ||
EBITDA | -$5.5M | ||
Net Working Capital | $35.9M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | 3 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 12 | ||
P/E | -5 | ||
PEG | -1 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 08/11/2020 | ||
Earnings & Revenue